• Publications
  • Influence
Post‐Traumatic Stress Disorder in Canada
Post‐traumatic stress disorder (PTSD) has become a global health issue, with prevalence rates ranging from 1.3% to 37.4%. As there is little current data on PTSD in Canada, an epidemiological studyExpand
  • 227
  • 28
The impact of anxiety disorders on educational achievement.
Anxiety disorders typically have an age of onset in childhood and adolescence, resulting in significant disability in social and occupational functioning. Epidemiological evidence suggests thatExpand
  • 397
  • 14
Childhood maltreatment linked to greater symptom severity and poorer quality of life and function in social anxiety disorder
Background: There is a paucity of data examining the prevalence and impact of childhood maltreatment in patients presenting with a primary diagnosis of social anxiety disorder (SAD). We thus examinedExpand
  • 113
  • 13
A confirmatory factor analysis of a self-report version of the Liebowitz Social Anxiety Scale.
One of the most popular measures of social phobia is the Liebowitz Social Anxiety Scale (LSAS; Liebowitz, 1987). The LSAS is a 24-item semi-structured interview measure of fear and avoidanceExpand
  • 90
  • 8
The relationship of behavioral inhibition and shyness to anxiety disorder.
Behavioral inhibition to the unfamiliar is a temperamental construct that refers to a characteristic propensity to react to both social and nonsocial novelty with inhibition. In contrast, shynessExpand
  • 98
  • 7
Relationship of social phobia with other psychiatric illness.
Fifty-seven social phobic patients were studied to identify the comorbidity with other psychiatric illnesses and their temporal relationships. Mood disorders, particularly major depression, was theExpand
  • 171
  • 6
Individuals with social phobia are biased to become aware of negative faces
To evaluate whether individuals with social phobia are biased to become aware of negative faces participants searched visual displays containing varying number of neutral face distractors for theExpand
  • 73
  • 6
An open trial of topiramate in the treatment of generalized social phobia.
BACKGROUND Selective serotonin reuptake inhibitors (SSRIs) are the current gold standard in the pharmacologic treatment of generalized social phobia. SSRIs are only effective in approximately 50% ofExpand
  • 68
  • 4
A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania.
BACKGROUND Trichotillomania has been considered as part of the obsessive-compulsive disorder spectrum; however, trichotillomania treatment with obsessive-compulsive disorder medications has largelyExpand
  • 92
  • 3
Nefazodone in the treatment of generalized social phobia: a randomized, placebo-controlled trial.
OBJECTIVE Numerous studies have demonstrated the efficacy of serotonergic antidepres-sants, particularly the selective serotonin reuptake inhibitors (SSRIs), in the treatment of social phobia. WeExpand
  • 28
  • 3